DECIPHER brought together its academic, clinical, and industrial partners for its Scientific Day—a milestone event dedicated to pioneering therapeutic approaches in oncology, with major breakthroughs highlighted in hemato-oncology and other…

On 25 September 2026, LabCom DECIPHER (DEcoding Cancer resistance via Integrated PHarmacogenomics and Epigenetics Research) will host its first open scientific seminar at CIRM, Luminy Campus (Marseille).  Born from a…

Our latest work : “Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia” has just been published in HemaSphere. This study reveals how ALDH1A1 and…

Marseille, June 2025 – The DECIPHER project, led by Salvatore Spicuglia from TAGC (Inserm) and Mileidys Perez from Advanced BioDesign (ABD), has been selected as one of the 2024 winners…